A new study testing 1,008 AI-generated SVGs across 48 animal-vehicle combinations finds no evidence that AI labs are secretly 'pelicanmaxxing' — gaming Simon Willison's famous pelican-on-a-bicycle SVG benchmark — with pelicans ranking 6th out of 8 animals in drawing quality, suggesting broad SVG optimization rather than targeted benchmark manipulation.
Replit raises $400M at a $9B valuation — tripling in just six months — while launching Agent 4, a 10x faster AI coding tool, as the platform targets $1B in run-rate revenue by 2026 with 50 million users and Fortune 500 clients worldwide.
The U.S. Department of Energy selects 278 projects under its record-breaking Genesis Mission, spanning all 50 states and 342 institutions, to accelerate AI-driven scientific discovery in energy, national security, and beyond, with the largest single award being a $60 million investment in AI-powered nuclear energy research.
The Trump Administration commits over $5 billion to the 'Genesis Mission,' a sweeping AI-powered federal initiative spanning 15+ agencies aimed at curing pediatric cancer, expanding the power grid, and doubling America's R&D output through shared data, computing power, and cutting-edge scientific collaboration.
AMD commits up to $5 billion in a landmark investment in Anthropic, launching a major multi-year partnership to deploy 2 gigawatts of AMD Instinct MI450 GPU-powered AI infrastructure starting in early 2027.
Poolside emerges from 18 months of silence with its open-source AI model Laguna, which rivals top American and Chinese competitors despite being a fraction of their size, while the startup also holds an unreported stake in Fluidstack now worth roughly $860 million following the neocloud's $830 million raise.
Chinese AI giants Moonshot and Alibaba are unveiling powerful new frontier models — Kimi K3 and Qwen3.8 — claiming to rival top US systems from OpenAI and Anthropic at a fraction of the cost, with both companies making their advanced models publicly available in a move that signals America's lead …
AI is slashing drug development costs by up to 70% and driving a projected $1 billion surge in new biopharma spending, but critics warn that no AI-discovered drug has yet received FDA approval, and the industry's notorious 90% failure rate may persist if human biological variability isn't properly addressed before …
CAISI Director Chris Fall resigns after just three months on the job, with NIST Chief Dr. Arvind Raman stepping in as Acting Director while the Trump administration searches for a permanent replacement in the coming weeks.
Alibaba shares surge 5.4% after launching its flagship Qwen3.8 Max AI model, boasting 2.4 trillion parameters and claiming second place only to Anthropic's best, intensifying fears that China is rapidly closing the AI gap with global leaders.